Biden “Promoting Competition” Executive Order Falls In Behind Drug Importation
FDA Law
JULY 12, 2021
Kirschenbaum — On Friday, President Biden issued a wide ranging Executive Order seeking to address overconcentration, monopolization, and unfair competition in the U.S. Among the Order’s mandates for DHHS are several relating to prescription drugs. The Executive Order places the Biden Administration firmly behind drug importation.
52 
Let's personalize your content